Document Mentions (4 shared documents)

EFTA00136746

2 mentions1 same-page

Page ?Same page

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

out of China." CBS News <https://www.cbsnews.coin/news/house-intelligence-committee-report-china-us-intelligence-not- sufficiently-adapted/> (9/30, Gazis, 3.68M) says that the report, "based on hundreds of hours of interviews with EFTA00136755 intelligence officers and quality checks of thousands of

EFTA00135712

2 mentions1 same-page

Page ?Same page

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

nalizing this report. At least for us it really does crystallize some of the nontraditional threats that can emanate out of China." CBS News (9/30, Gazis, 3.68M) says that the report, "based on hundreds of hours of interviews with intelligence officers and quality checks of thousands of analytic produ

EFTA00148896

2 mentions1 same-page

Page ?Same page

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human